However, here is some general guidance on factors that would determine the potential place of a new antidiabetic medication like CT-996 in the therapeutic landscape, based on common considerations: Efficacy : CT-996 would need to demonstrate substantial efficacy in reducing blood glucose levels, indicated by parameters such as HbA1c reductions
Cells are dependent on glutamine in so many ways, says Natasha Pavlova, a biochemist who studies cancer metabolism in the lab of MSK President and CEO Craig Thompson in the Sloan Kettering Institute
How come GLP-1 RAs are not prescribed more by cardiologists
By combining modern telehealth technology with personalized medical supervision, we make it possible for you to access clinical weight loss tools from the comfort of your home
What are the criteria for insurance approval for using Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), for weight loss?